News Category: Press Release

Two Scripps Research assistant professors named 2026 Baxter Young Investigators

The Baxter Foundation annually support early-career researchers whose work in science and technology holds promise for improving patient care.

A fentanyl countermeasure that adapts to combat future black-market drugs

Scripps Research scientists developed a vaccine that teaches the immune system to rapidly neutralize fentanyl and new emerging synthetic fentanyl analogs.

Chemists snap together complex 3D molecules from highly reactive ‘radicals’—without losing their shape

Scripps Research team develops stereoretentive radical-radical cross-coupling, a simpler way to build chiral drug candidates.

Calibr-Skaggs advances CLF065, a regenerative GLP-2 therapy, into two Phase 2 IBD studies

CLF065, a long-acting, once-weekly GLP-2 receptor agonist, advances in two inflammatory bowel disease indications. The studies aim to bring a regenerative treatment option to patients living with IBD, who currently have few therapies that repair the damaged intestinal lining at the root of their disease.

Experimental HIV vaccine achieves a long-sought goal

In a first for the field, all non-human primates given a new series of vaccines generated antibodies capable of fighting multiple strains of HIV.

Scripps Research chemist Jin-Quan Yu is named a Fellow of the Royal Society

Yu is honored by the U.K.’s national academy of sciences for his work in synthetic organic chemistry.

Scripps Research’s Skaggs Graduate School awards doctoral degrees to 34th graduating class

Scripps Research establishes endowed chair honoring renowned structural biologist Ian Wilson

Keren Lasker to be inaugural chair holder

How changes to proteins can alter drug interactions for new precision therapies

Scripps Research team maps how chemical modifications to proteins affect drug binding across the human proteome.

Scripps Research immunologist Dennis Burton elected to American Academy of Arts and Sciences

A leader in broadly neutralizing antibodies, Burton has helped drive global efforts to develop vaccines for HIV, influenza and more.